What is the success rate of imatinib for treating chronic myeloid leukemia?
Imatinib has shown excellent success rates for treating CML. Almost all people with CML who take imatinib respond well, and many maintain that response for years.
Here are the key success metrics:
* About 70% of people achieve a complete Show Full Answer
What is the success rate of imatinib for treating chronic myeloid leukemia?
Imatinib has shown excellent success rates for treating CML. Almost all people with CML who take imatinib respond well, and many maintain that response for years.
Here are the key success metrics:
* About 70% of people achieve a complete cytogenetic response, meaning the BCR-ABL gene is no longer detected
* Approximately 90% of people who use imatinib live at least five years after starting treatment
* The 10-year survival rate is around 83%
Imatinib typically reduces CML symptoms effectively. However, in some cases, the drug may stop working over time as leukemia cells develop resistance. When this happens, doctors may increase the dose or switch to a different tyrosine kinase inhibitor (TKI).
The introduction of imatinib in 2001 dramatically improved outcomes for people with CML, making it a highly effective first-line treatment option.
February 5
Join
Your Privacy Choices
